Cyblex MV 40.2 Tablet

By Cyblex MV

Rx

15 Tablet in a Strip

Composition icon

Composition

Voglibose(0.2mg) + Metformin(500mg) + Gliclazide(40mg)

Manufacturer - Eris Lifesciences Ltd icon

Manufacturer - Eris Lifesciences Ltd

8th Floor, Commerce House IV, Prahladnagar, Ahmedabad – 380015 Gujarat, India

Expires on or after icon

Expires on or after

July, 2027

About Cyblex MV 40.2 Tablet

Cyblex MV 40.2 Tablet, belonging to the class of antidiabetic medicines, is primarily used in the treatment of type 2 diabetes mellitus in adults. This chronic condition affects how the body processes glucose, leading to symptoms like frequent urination, increased hunger, and elevated blood sugar levels. By combining three antidiabetic drugs – Voglibose, Metformin, and Gliclazide – Cyblex MV 40.2 Tablet works to keep blood sugar levels under control.

Voglibose, an alpha-glucosidase inhibitor, helps prevent the rapid increase in sugar levels after meals by inhibiting the breakdown of complex sugars into glucose. Gliclazide, categorized as a sulfonylurea, stimulates increased insulin production by the pancreas. Metformin, a biguanide, reduces glucose production in the liver, delays glucose absorption in the intestines, and enhances the body's response to insulin. Together, these components of Cyblex MV 40.2 Tablet work synergistically to prevent blood sugar spikes, thus aiding in the management of diabetes.

It is crucial to take Cyblex MV 40.2 Tablet with food to prevent stomach upset and maintain consistency by consuming it at the same time each day for optimal results. Dosage adjustments should be made based on your doctor's recommendations, which may change periodically depending on your blood sugar levels. It is essential to continue taking the medication as prescribed, even if you feel well, to avoid potential risks like kidney damage, vision impairment, nerve problems, or limb loss due to uncontrolled blood sugar levels.

One of the common side effects of Cyblex MV 40.2 Tablet is hypoglycemia, characterized by symptoms such as dizziness, sweating, and hunger pangs. Regular meals and carrying a quick-acting glucose source can help prevent this condition. Other possible side effects may include changes in taste, nausea, diarrhea, headache, and stomach pain. It is essential not to discontinue the medication abruptly without consulting your doctor, as this can lead to a dangerous increase in blood sugar levels and potentially serious complications associated with diabetes.

Individuals with type 1 diabetes mellitus, diabetic ketoacidosis, or severe kidney or liver disease should not take Cyblex MV 40.2 Tablet. If you have a history of heart disease, are pregnant, planning pregnancy, or breastfeeding, it is important to inform your healthcare provider before starting this medication. Regular monitoring of blood sugar levels and potential blood tests may be recommended to ensure the medication's efficacy and safety. Maintaining a healthy lifestyle, including weight management, regular exercise, and a balanced diet, is also crucial in effectively managing diabetes alongside Cyblex MV 40.2 Tablet.


Benefits

Cyblex MV 40.2 Tablet is a powerful combination of three essential anti-diabetic medications: Voglibose, Metformin, and Gliclazide. Voglibose, an alpha-glucosidase inhibitor, works by preventing the breakdown of complex sugars into glucose, thus avoiding sudden spikes in blood sugar levels after meals. Gliclazide, a 'sulfonylurea', stimulates the pancreas to release more insulin, helping to regulate blood sugar levels effectively. Metformin, a 'biguanide', aids in reducing glucose production in the liver, slowing down glucose absorption from the intestines, and improving the body's sensitivity to insulin. By working together, these three medications maintain blood glucose levels within a healthy range, effectively managing Diabetes.


Cyblex MV 40.2 Tablet not only helps to control blood sugar levels but also plays a crucial role in preventing the serious complications that can arise from uncontrolled Diabetes. It is vital to maintain strict control over blood sugars to avoid the disabling effects associated with the condition. This medication is most effective when complemented with lifestyle changes like weight management, regular physical activity, and a balanced diet. Adopting these healthy habits along with Cyblex MV 40.2 Tablet can optimize its benefits and help individuals with Diabetes lead a better quality of life.


How to use the Cyblex MV 40.2 Tablet

When using the Cyblex MV 40.2 Tablet, it is important to follow your doctor's instructions regarding the dose and duration. Take the tablet with food to avoid any potential stomach discomfort. Swallow the tablet whole with a glass of water; do not crush, chew, or break it before swallowing. By taking the tablet as directed, you can ensure the best effectiveness of the medication. Make sure to always consult your doctor for proper guidance on using this tablet for your specific condition.


Uses of Cyblex MV 40.2 Tablet

The Cyblex MV 40.2 Tablet is commonly prescribed for the management of Type 2 Diabetes Mellitus. This medication is used to help control blood sugar levels in individuals with this condition. By taking the Cyblex MV 40.2 Tablet as directed by a healthcare provider, patients can improve their ability to regulate their blood glucose levels effectively. This tablet plays a key role in the treatment plan for those with Type 2 Diabetes Mellitus, as it works to support overall health and wellbeing by assisting in the control of blood sugar.


What conditions Cyblex MV 40.2 Tablet treats?

Cyblex MV 40.2 Tablet is used for managing Diabetes Mellitus type 2. In type 2 diabetes, the body may not produce enough insulin or may have resistance to insulin, leading to high blood sugar levels. Symptoms include fatigue, thirst, blurry vision, and frequent urination. Complications of type 2 diabetes can affect the skin, eyes, nerves, wounds, feet, kidneys, and heart, and may result in stroke if not managed properly. Maintaining blood sugar levels within a normal range is essential to prevent these complications.


Should you consult a doctor?

It is important to seek medical attention if you experience persistent side effects while taking Cyblex MV 40.2 Tablet. The most common side effects include low blood glucose levels (hypoglycemia), nausea, abdominal pain, and constipation. If these side effects persist or if you are concerned about them, consult your doctor for guidance.


Additionally, it is crucial to consult your doctor before stopping the medication. If you discontinue Cyblex MV 40.2 Tablet without medical advice, your blood sugar levels may increase, putting you at risk of severe complications such as kidney damage, blindness, nerve problems, and limb loss. It is essential to follow your doctor's instructions regarding the dosage and timing of the medication to effectively manage your diabetes.


If you have type 1 diabetes mellitus, diabetic ketoacidosis, or severe kidney or liver disease, do not take Cyblex MV 40.2 Tablet without consulting your doctor. Pregnant or breastfeeding women should also seek medical advice before starting this medication. Regular monitoring of blood sugar levels and periodic blood tests may be necessary to ensure the safety and efficacy of the treatment.


Side effects of Cyblex MV 40.2 Tablet

When taking Cyblex MV 40.2 Tablet, you may experience side effects. Most of these side effects are mild and usually go away as your body gets used to the medicine. However, if these side effects persist or cause you concern, it's important to consult your doctor. Some common side effects of Cyblex MV 40.2 Tablet include nausea, abdominal pain, and constipation. Additionally, there is a risk of hypoglycemia, which is low blood glucose levels. Symptoms of hypoglycemia can include dizziness, sweating, palpitations, hunger pangs, as well as dry mouth and skin. If you experience any of these side effects, it's advisable to seek medical advice.


Safety advice

scroll

liver

When it comes to the safety of your liver, it is important to be cautious while using Cyblex MV 40.2 Tablet. Patients with liver disease should take this medication with care, as it may require a dose adjustment. It is advisable to consult your doctor before starting Cyblex MV 40.2 Tablet. Typically, in individuals with mild to moderate liver disease, the medication is initially prescribed in a low dose. However, for patients with severe liver disease, the use of Cyblex MV 40.2 Tablet is not recommended. Take special care and always seek guidance from your healthcare provider to ensure the safe and appropriate use of this medication.

scroll

kidney

Cyblex MV 40.2 Tablet requires caution in kidney disease. Dosage adjustment and doctor consultation may be necessary. Not advised for severe kidney disease. Monitor kidney function regularly during use.

scroll

alcohol

It is not safe to drink alcohol while taking Cyblex MV 40.2 Tablet. It is advised to avoid alcohol consumption for safety.

scroll

driving

When your blood sugar is too low or high, it can affect your driving ability. It's best not to drive if you experience any of these symptoms.

scroll

pregnancy

Cyblex MV 40.2 Tablet is considered unsafe during pregnancy, as animal studies suggest potential harm to the fetus. Consult your doctor to discuss any risks and benefits associated with its use during pregnancy.

scroll

breastfeeding

Caution should be taken when using Cyblex MV 40.2 Tablet while breastfeeding. It is recommended to wait until the mother's treatment is finished and the drug is no longer in her system.


Consumption warning before consuming Cyblex MV 40.2 Tablet

Before taking Cyblex MV 40.2 Tablet, it is crucial to be aware of certain risks. Some diabetic patients using this medication may develop a severe condition known as lactic acidosis, where too much lactic acid builds up in the blood. Proper liver and kidney function are necessary to eliminate excess lactic acid. Therefore, individuals with kidney disease should avoid this tablet. Additionally, Cyblex MV 40.2 Tablet can reduce vitamin B12 levels, necessitating regular blood tests. It may also lead to a significant decrease in blood sugar levels when combined with or without insulin, potentially requiring a reduction in insulin dosage by your doctor. Furthermore, this medication can lower your thyroid-stimulating hormone (TSH), making it advisable to have an annual TSH check-up. Monitoring these factors is essential before consuming Cyblex MV 40.2 Tablet.


Disease interactions

When considering Cyblex MV 40.2 Tablet, it’s important to note that individuals with certain health conditions should avoid using this medication. Patients with vitamin B12 deficiency, kidney problems, liver problems, cardiovascular disease, and low blood sugar levels should steer clear of Cyblex MV 40.2 Tablet as it has the potential to exacerbate these conditions. It is advisable for individuals with these health issues to consult with their healthcare provider before taking this medication to avoid any potential risks or complications.


Additional Information

Habit FormingNo
Chemical Class-
Therapeutic ClassANTI DIABETIC
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

248.56

Inclusive of all taxes

Content verified by

chevron-right

Dr. Archana Prabhakar

MBBS, M.Med (Family Medicine)

Last update on 01-Oct-2024